These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1001865)

  • 1. Clinical value of protein-bound fucose in patients with carcinoma and other diseases.
    Lambana S
    Gan; 1976 Jun; 67(3):379-88. PubMed ID: 1001865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC; Rao BB
    Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors.
    Tatsumura T; Sato H; Mori A; Komori Y; Yamamoto K; Fukatani G; Kuno S
    Cancer Res; 1977 Nov; 37(11):4101-3. PubMed ID: 908042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
    Parwani RN; Parwani SR
    J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein bound fucose (PBF) in untreated leprosy patients.
    Venkatesan K; Bharadwaj VP; Sritharan V; Girdhar BK; Ramu G; Desikan KV
    Lepr India; 1981 Oct; 53(4):531-6. PubMed ID: 7334781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-fetoprotein in non-hepatocellular malignant tumors].
    Wang PY
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):61-3. PubMed ID: 1716196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of protein bound serum fucose in cancer of the breast.
    Hadjivassiliou A; Castanaki A; Hristou G; Lissaios B
    Surg Gynecol Obstet; 1975 Feb; 140(2):239-40. PubMed ID: 1124474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fucose level in malignant diseases.
    Sawke NG; Sawke GK
    Indian J Cancer; 2010; 47(4):452-7. PubMed ID: 21131761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fucosylation of serum proteins in stomach cancer].
    Sorkin VM; Borisenko SN; Kasymova GA
    Vopr Med Khim; 1987; 33(4):49-52. PubMed ID: 3660739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
    Li R; Li R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fucosyl transferase activity and serum fucose levels as diagnostic tools in malignancy.
    Sen U; Guha S; Chowdhury JR
    Acta Med Okayama; 1983 Dec; 37(6):457-62. PubMed ID: 6666675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fucose levels in gynaecological disorders including carcinoma cervix.
    Bandlish U; Prabhakar BR; Virmani U
    J Indian Med Assoc; 1991 Sep; 89(9):250-1. PubMed ID: 1795106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.